Epithelial ovarian cancer has been identified as the most prevalent type of ovarian cancer. It generally affects the epithelial tissue, which refers to a thin lining covering the outer part of the ovary. More than 21,400 patients were diagnosed with ovarian cancer in 2021, epithelial ovarian cancer accounted for at least nine cases out of ten. Individuals over 65 years old generally comprise the majority of epithelial ovarian cancer cases.

At present, clinicians diagnose 75% of ovarian cancers cases at a late stage. Those cases are usually characterized by the spread of the tumors. Early detection of the disease helps advance treatment and save lives. Early research has advocated investigating DNA alterations to predict the probability of developing cancers. A recent article published in Nature Communications (open access) has suggested that cells acquired while screening for cervical cancer could be used to detect ovarian cancers.

Tissues that have been embryologically extracted from the Müllerian Duct (the embryonic structure that forms the female reproductive system) are the origin of most cases of epithelial ovarian cancer. Martin Widschwendter and collaborators collected samples of cervical cells from a cohort comprising 242 women with ovarian cancer and 869 without ovarian cancer. The researchers assessed approximately 14,000 epigenetic modifications, molecular variations that change gene expression patterns without altering the DNA itself, in the samples screened by them. Subsequently, they recognized a DNA methylation signature, which represents a unique alteration pattern for rare diseases, and considered it feasible for recognizing or predicting ovarian cancer. 

The team referred to this signature as the WIDOC index: the Women’s risk IDentification for Ovarian Cancer index. They discovered that this signature enabled the identification of 71.4% of women aged under 50 years and 54.5% women aged over 50 years with ovarian cancers, with 75% of individuals without the disease displaying a negative test.

Previous reports mentioned that the majority of epithelial ovarian cancer cases are high-grade serous carcinomas, which spread rapidly on reaching the ovaries. Moreover, they become metastatic by the time a patient is diagnosed. Findings of the recent article were additionally corroborated in a supplementary cohort. 47 of these women had ovarian cancer, whereas 227 did not. The research team identified that women with greater scores may display an augmented risk of ovarian cancer.

The researchers also performed a second study, where they originally examined epigenetic variations in samples of cervical cells obtained from 869 women without breast cancer and 329 women with breast cancer who displayed poor prognoses. They were able to successfully recognize women with breast cancer. Therefore, the research team specifies that the utilization of epigenetic signatures of DNA methylation will possibly help in the detection and prevention of ovarian and breast cancers. Nevertheless, they identified the need for additional investigation and far-reaching prospective clinical research to determine the efficacy of these tests in foreseeing the probability of women being affected with either of these cancers.

References

  • Barrett, J. E., Jones, A., Evans, I., Reisel, D., Herzog, C., Chindera, K., … & Widschwendter, M. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nature Communications13(1), 1-12. https://doi.org/10.1038/s41467-021-26615-y
  • Clyde, M. A., Palmieri Weber, R., Iversen, E. S., Poole, E. M., Doherty, J. A., Goodman, M. T., … & Ovarian Cancer Association Consortium. (2016). Risk prediction for epithelial ovarian cancer in 11 United States–Based case-control studies: incorporation of epidemiologic risk factors and 17 confirmed genetic loci. American journal of epidemiology184(8), 555-569. https://doi.org/10.1093/aje/kww091
  • Dubeau, L., & Drapkin, R. (2013). Coming into focus: the nonovarian origins of ovarian cancer. Annals of oncology24, viii28-viii35. https://doi.org/10.1093/annonc/mdt308
  • Cleveland Clinic. (2022, March 1). Epithelial Ovarian Cancer: Types, Stages, Symptoms & Causes. Retrieved February 8, 2022, from https://my.clevelandclinic.org/health/diseases/22250-epithelial-ovarian-cancer

Illustration by Gretchen Andrew.

I have always been fascinated by the living world, particularly the human brain, which eventually led me to a post-graduate degree in Neuroscience. I am a science enthusiast and always try to remain updated with the latest happenings in the field of medicine and biotechnology. I began my professional career as an Academic Writer (Nursing and Medical), besides acquiring a post-graduate diploma in Medical writing. I have also worked as a project fellow in Genetics, where my principal role involved working with the Indian Genetic Disease Database. Currently, I am focused on editing manuscripts of non-native English language speakers and making them publication-ready. Of late, I have gained interest in science journalism and the ways to disseminate accurate information to the mass. My hobbies include baking, photography, and reading thrillers and detective novels.

Leave a Reply